• Phase
  • This is a Phase II, Double-Blind, Randomized, Placebo-Controlled, Multi-center Trial enrolling 120 subjects with Bacterial Vaginosis who will be randomized at a ratio of 2:1 to receive active test article (5% Monolaurin Vaginal Gel) or placebo (vehicle). (clinicaltrials.gov)
  • prevalence
  • Janulaitiene M, Paliulyte V, Grinceviciene S, Zakareviciene J, Vladisauskiene A, Marcinkute A, Pleckaityte M (2017) Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis. (springer.com)